These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 20112882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR.
    Am Fam Physician; 2010 Feb 01; 81(3):298-303. PubMed ID: 20112888
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A, Allan N, Wills B, Kang C, Leikin JB.
    Clin Toxicol (Phila); 2011 Jul 01; 49(6):443-7. PubMed ID: 21591886
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
    Willy ME, Li Z.
    Pharmacoepidemiol Drug Saf; 2004 Apr 01; 13(4):201-6. PubMed ID: 15255086
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FDA electronic drug labels to improve patient safety.
    J Pain Palliat Care Pharmacother; 2006 Apr 01; 20(2):96-7. PubMed ID: 16789334
    [No Abstract] [Full Text] [Related]

  • 10. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE, Faich GA, Bormel FG, Sasinowski FJ.
    Food Drug Law J; 1998 Apr 01; 53(3):403-11. PubMed ID: 10346718
    [No Abstract] [Full Text] [Related]

  • 11. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J.
    Food Drug Law J; 1995 Apr 01; 50(4):533-51. PubMed ID: 10343018
    [No Abstract] [Full Text] [Related]

  • 12. Bringing greater transparency to "black box" warnings.
    Buckley NA, Rossi S.
    Clin Toxicol (Phila); 2011 Jul 01; 49(6):448-51. PubMed ID: 21824055
    [Abstract] [Full Text] [Related]

  • 13. Coverage of FDA medication boxed warnings in commonly used drug information resources.
    Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD.
    Arch Intern Med; 2010 May 10; 170(9):831-3. PubMed ID: 20458094
    [No Abstract] [Full Text] [Related]

  • 14. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT, Barash PG.
    Anesth Analg; 2009 Jan 10; 108(1):211-8. PubMed ID: 19095852
    [Abstract] [Full Text] [Related]

  • 15. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service.
    J Pain Palliat Care Pharmacother; 2006 Jan 10; 20(1):49-55. PubMed ID: 16687359
    [Abstract] [Full Text] [Related]

  • 16. Black box warnings-implications in practice.
    Zarowitz BJ.
    Geriatr Nurs; 2008 Jan 10; 29(6):402-9. PubMed ID: 19064138
    [No Abstract] [Full Text] [Related]

  • 17. The significance of mitochondrial toxicity testing in drug development.
    Dykens JA, Will Y.
    Drug Discov Today; 2007 Sep 10; 12(17-18):777-85. PubMed ID: 17826691
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.